Canlyniadau Chwilio - Böhler, Torsten

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients gan Kamar, Nassim, Cointault, Olivier, Böhler, Torsten, Esposito, Laure, Rostaing, Lionel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer gan Wang, Qi, Alshaker, Heba, Böhler, Torsten, Srivats, Shyam, Chao, Yimin, Cooper, Colin, Pchejetski, Dmitri

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1 gan Alshaker, Heba, Wang, Qi, Kawano, Yoshiaki, Arafat, Tawfiq, Böhler, Torsten, Winkler, Mathias, Cooper, Colin, Pchejetski, Dmitri

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1 gan Alshaker, Heba, Wang, Qi, Böhler, Torsten, Mills, Robert, Winkler, Mathias, Arafat, Tawfiq, Kawano, Yoshiaki, Pchejetski, Dmitri

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Pharmacodynamic Evaluation of the First Dose of Mycophenolate Mofetil Before Kidney Transplantation gan Kamar, Nassim, Glander, Petra, Nolting, Jochen, Böhler, Torsten, Hambach, Pia, Liefeldt, Lutz, Rostaing, Lionel, Neumayer, Hans-Hellmut, Budde, Klemens

Cael y testun llawn Cael y testun llawn Cael y testun llawn